Status:
COMPLETED
Evaluation of the QuantiFERON-TB Test.
Lead Sponsor:
QIAGEN Gaithersburg, Inc
Conditions:
Tuberculosis
Eligibility:
All Genders
18-80 years
Brief Summary
To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.
Detailed Description
To compare the specificity of the CST001 assay to the QFT Gold Test in low TB exposure risk subjects and non-tuberculosis mycobacterial infections.
Eligibility Criteria
Inclusion
- Low-exposure Risk Group
- No identified risk factors for TB infection
Exclusion
- Age less than 18 years or greater than 80 years
- Identified Risk Factors For TB Infection
- Non-tuberculous mycobacterial infection Group
- Inclusion Criteria:
- history of nontuberculous mycobacterial disease (pulmonary or extrapulmonary) in accordance with the 2007 ATS/IDSA criteria
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT02256839
Start Date
October 1 2014
End Date
October 1 2015
Last Update
August 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Sciences University
Portland, Oregon, United States, 97239